Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor
- OPACC
- Aug 8
- 1 min read
A groundbreaking study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights into the biology of embryonal tumor with multilayered rosettes (ETMR), a rare and aggressive brain tumor affecting young children.
Comments